Exelon Corp Stock Buy Recommendation Reiterated (EXC)
Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.NEW YORK (TheStreet) -- Exelon (NYSE:EXC) has been reiterated by TheStreet Ratings as a buy with a ratings score of B- . The company's strengths can be seen in multiple areas, such as its revenue growth and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself.
- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass
- The revenue growth came in higher than the industry average of 0.0%. Since the same quarter one year prior, revenues rose by 24.0%. This growth in revenue does not appear to have trickled down to the company's bottom line, displayed by a decline in earnings per share.
- The debt-to-equity ratio is somewhat low, currently at 0.89, and is less than that of the industry average, implying that there has been a relatively successful effort in the management of debt levels. Although the company had a strong debt-to-equity ratio, its quick ratio of 0.79 is somewhat weak and could be cause for future problems.
- Net operating cash flow has declined marginally to $1,828.00 million or 3.99% when compared to the same quarter last year. Despite a decrease in cash flow of 3.99%, EXELON CORP is in line with the industry average cash flow growth rate of -5.36%.
- The share price of EXELON CORP has not done very well: it is down 22.99% and has underperformed the S&P 500, in part reflecting the company's sharply declining earnings per share when compared to the year-earlier quarter. Despite the stock's decline during the last year, it is still somewhat more expensive (in proportion to its earnings over the last year) than most other stocks in its industry. We feel, however, that other strengths this company displays offset this slight negative.
- EXELON CORP has exprienced a steep decline in earnings per share in the most recent quarter in comparison to its performance from the same quarter a year ago. Earnings per share have declined over the last two years. We anticipate that this should continue in the coming year. During the past fiscal year, EXELON CORP reported lower earnings of $3.75 versus $3.86 in the prior year. For the next year, the market is expecting a contraction of 26.7% in earnings ($2.75 versus $3.75).
--Written by a member of TheStreet Ratings Staff.FREE for a limited time only: Get TheStreet Ratings #1 Stock Report NOW!
Latest Headlines about EXC
-
Dow Utilities Remain Buy Rated
08:01AM 05/14/13
-
Solar Scores a Big Win Over Nuclear
06:15AM 05/04/13
-
Analysts' Actions: BEN CNX EXC REGN STX
08:50AM 05/02/13
-
Dow Utilities Outperform S&P 500 in First Quarter
09:10AM 04/02/13
-
Cramer's 'Mad Money' Recap: Focus on the Positive
08:19PM 03/04/13
-
'Mad Money' Lightning Round: I Believe in Priceline
06:00AM 02/21/13
-
Cramer's 'Mad Money' Recap: One Bad Day Means Nothing
07:46PM 02/20/13
Latest from TheStreet Wire
-
Medical Stock Hits New 52-Week High (MPW)
02:48PM 05/21/13
-
Panera Bread Stock Hits New 52-Week High (PNRA)
02:45PM 05/21/13
-
Owens-Illinois Reaches New 52-Week High (OI)
02:45PM 05/21/13
-
Dow Today: Pfizer (PFE) Higher Dow Today: Pfizer (PFE) Lower
02:39PM 05/21/13
-
Illinois Tool Works Reaches New 52-Week High (ITW)
02:38PM 05/21/13
-
Warner Chilcott Reaches New 52-Week High (WCRX)
02:09PM 05/21/13
-
American Express Reaches New 52-Week High (AXP)
02:02PM 05/21/13
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
